A/S Novo Nordisk (manufacturer of medicinal product, primary and secondary packaging; manufacturer responsible for batch release of final product; manufacturer of medicinal product, primary packaging, lyophilization and control of finished medicinal product. Quality control of finished medicinal product. Manufacturer for assembly, labeling and packaging, secondary packaging)

The drug is used to treat severe states of low blood sugar (hypoglycemia) in adults and children with insulin-dependent diabetes mellitus. It is also used for diagnostic procedures to slow down intestinal motility.

Dosage form: lyophilisate for solution for injection

ATC: H04AA01